Phillyrin's Effects on Streptococcus suis
Author Information
Author(s): Yuan Fangyan, Zheng Lihan, Wang Mengzhe, Liu Wei, Li Xiaoyue, Gao Ting, Guo Rui, Liu Zewen, Yang Keli, Li Chang, Wu Qiong, Zhu Jiajia, Tian Yongxiang, Zhou Danna, Beddoe Travis
Primary Institution: Key Laboratory of Prevention and Control Agents for Animal Bacteriosis, Hubei Academy of Agricultural Sciences
Hypothesis
Phillyrin can inhibit the growth and biofilm formation of Streptococcus suis and improve the survival rate in infected mice.
Conclusion
Phillyrin shows potential as a candidate for preventing and treating Streptococcus suis infections due to its antibacterial and anti-inflammatory properties.
Supporting Evidence
- Phillyrin significantly inhibited the growth of Streptococcus suis in vitro.
- Phillyrin reduced biofilm formation of Streptococcus suis.
- Phillyrin improved the survival rate of infected mice.
- Phillyrin decreased the secretion of inflammatory cytokines in infected mice.
- Phillyrin protected the integrity of tight junction proteins in epithelial cells.
Takeaway
Phillyrin, a natural compound, helps fight a harmful bacteria that can make both pigs and humans sick, and it might be a good alternative to antibiotics.
Methodology
The study used in vitro and in vivo experiments to evaluate the effects of phillyrin on Streptococcus suis, including minimum inhibitory concentration (MIC) tests, electron microscopy, and animal trials.
Limitations
The detailed molecular mechanism of phillyrin's action on Streptococcus suis remains unclear.
Participant Demographics
Five-week-old female specific pathogen-free (SPF) BALB/c mice were used in the animal experiments.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website